Clinical trials: Height Phobia
Phobic Disorders
D-Cycloserine to Enhance Cognitive Behavioral Therapy (CBT) for Acrophobia
The purpose of this study is to investigate the utility of post-session administration of D-cycloserine to enhance fear extinction in a sample of people with acrophobia who will be treated with CBT.
- Trial name
- NCT01102803
- Testing
- Individual Cognitive Behavioral Therapy (CBT), D-Cycloserine
- Where
- United States
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Southern Methodist University
Specific Phobia
Self-efficacy Enhancement and Exposure Therapy
Self-efficacy refers to the perceived belief to cope effectively, by personal efforts, with challenging situations and problems (Bandura, 1977).
- Trial name
- NCT03105024
- Testing
- Self-efficacy enhancement, Control intervention
- Where
- Germany
- Volunteers
- 71 people
- Sponsor
- Ruhr University of Bochum
Fear of Heights, Specific Phobia, Situational
Self-efficacy Enhancement in a Virtual Reality Training for Fear of Heights
Self-efficacy (SE) enhancement after virtual reality exposure (VRET) for heights can promote treatment-induced effects (Raeder et al. 2019).
- Trial name
- NCT05824884
- Testing
- Visual Feedback, Self-efficacy enhancement:, No visual feedback
- Where
- Germany
- Volunteers
- 83 people
- Sponsor
- Ruhr University of Bochum
Fear of Heights, Acrophobia
Virtual Reality Exposure Versus In Vivo Exposure for Fear of Heights
This study randomly assigned 114 participants with significant fear of heights to one of three conditions: a) a single session of virtual reality exposure; b) a single session of in vivo exposure; or c) a control condition.
- Conditions
- Fear of Heights, Acrophobia, Specific Phobia, Anxiety Disorder
- Trial name
- NCT04737915
- Testing
- Exposure Therapy (In Vivo), Exposure Therapy (Virtual Reality)
- Where
- United States
- Volunteers
- 114 people
- Sponsor
- University of Notre Dame
Height Phobia
D-Cycloserine-Enhancer of One-Session Treatment for Phobia of Heights
The study will determine the effects of D-Cycloserine (DCS) on fear reduction in patients diagnosed with phobia of heights (acrophobia) undergoing one session of three hours of virtual reality exposure therapy (VRET) or in vivo…
- Trial name
- NCT01037101
- Testing
- In Vivo Exposure Therapy, Virtual Reality Exposure Therapy, D-Cycloserine
- Where
- United States
- Volunteers
- 4 people, healthy volunteers welcome
- Sponsor
- CAMC Health System
Height Phobia, Fear of Heights
Changes in Brain Activity (Functional MRI Study) Before and After Behavioral Therapy of Height Phobia
We are interested in investigating the functional brain abnormalities of height phobia. Subjects will be have a functional MRI scan before and after a course of treatment with behavioral therapy.
- Trial name
- NCT00302978
- Testing
- Behavior therapy
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- New York State Psychiatric Institute
Fear of Spiders, Fear of Heights
Generalized Fear Extinction to Untreated Fear Stimuli in Specific Phobias After Exposure
This study investigates whether a one-session exposure treatment for spider-related stimuli can lead to a generalization of extinguished fear to height-related stimuli in individuals with comorbid fear of spiders and fear of…
- Trial name
- NCT03907345
- Testing
- Exposure
- Where
- Germany
- Volunteers
- 50 people
- Sponsor
- Ruhr University of Bochum
Ankle Sprains, Ankle Injuries
The Effect of Different Talocrural Joint Mobilization Techniques in Lateral Ankle Sprain
Decreased ankle dorsiflexion range of motion (DFROM) has been identified among the factors that increase the risk of lateral ankle sprain (LAS) in basketball players.
- Conditions
- Ankle Sprains, Ankle Injuries, Kinesiophobia, Jumping From Height
- Trial name
- NCT06295198
- Testing
- Single lep drop jump test
- Where
- Turkey (Türkiye)
- Volunteers
- 72 people
- Sponsor
- Bahçeşehir University
Phobia
TMS Augmented Exposure Therapy
This study investigates the beneficial effects of prefrontal brain stimulation (with a facilitating TMS protocol) before exposure therapy in acrophobic patients. The two exposure sessions were realized in virtual reality.
- Trial name
- BEAT (NCT02223767)
- Testing
- Experimental: Verum TMS
- Where
- Germany
- Volunteers
- 47 people
- Sponsor
- Wuerzburg University Hospital
Specific Phobia, Acrophobia
Virtual Reality Exposure Therapy for Acrophobia
The aim of this study is to examine the efficacy of virtual reality exposure therapy (VRET) as a treatment for specific phobia (acrophobia).
- Conditions
- Specific Phobia, Acrophobia, Fear of Heights, Anxiety Disorders
- Trial name
- NCT04975854
- Testing
- Exposure Therapy (Virtual Reality), Information Session
- Where
- Czechia
- Volunteers
- 43 people
- Sponsor
- National Institute of Mental Health, Czech Republic
Specific Phobia
Anti-phobic and Safety Behaviors in the Treatment of Acrophobia
This study tests whether a single session of exposure therapy may be enhanced by the addition of anti-phobic actions beyond the mere fading of safety behaviors.
- Trial name
- NCT02085343
- Testing
- EXP, EXP + SBF, EXP + SBF + AA
- Where
- United States
- Volunteers
- 100 people
- Sponsor
- University of Texas at Austin
Specific Phobia, Anxiety Disorders
Augmenting Virtual Reality Exposure Therapy for Acrophobia
This study will examine whether tactile feedback and point-based rewards can be used to improve outcomes from virtual reality exposure therapy for acrophobia.
- Conditions
- Specific Phobia, Anxiety Disorders, Fear of Heights, Acrophobia
- Trial name
- NCT03917433
- Testing
- Virtual Reality Exposure Therapy, Tactile Feedback, Point-based Rewards
- Where
- United States
- Volunteers
- 128 people
- Sponsor
- University of Nevada, Reno